• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿液BLCA-4在中国汉族人群中对膀胱癌检测具有高度特异性,且与肿瘤侵袭性相关。

Urinary BLCA-4 is highly specific for detection of bladder cancer in Chinese Han population and is related to tumour invasiveness.

作者信息

Feng C C, Wang P H, Guan M, Jiang H W, Wen H, Ding Q, Wu Z

机构信息

Department of Urology, Huashan Hospital, Fudan University, Shanghai, PR China.

出版信息

Folia Biol (Praha). 2011;57(6):242-7.

PMID:22264718
Abstract

BLCA-4 is currently the most sensitive and specific urinary marker for bladder cancer. As the incidence of bladder cancer varies by ethnic and territory, we tended to evaluate the feasibility of bladder cancer detection using urinary BLCA-4 in Chinese Han nationality. Urines from 79 bladder cancer patients, 31 urinary tract infection patients and 29 normal controls were included. Tissue specimens of 53 bladder cancers, 24 pathologically normal tumour- adjacent urothelium and 15 healthy controls were involved. BLCA-4 antibody was produced and applied in an indirect ELISA assay for urine samples and immunohistochemistry study in tissue samples. Urinary BLCA-4 was significantly higher in the bladder cancer group (P=0.0001). The level was in no relation to age, gender, growth pattern, grade or stage. Discrepant to reported data, a cut-off value of 1.7×10⁻⁴ A was acquired here, which yields a sensitivity of 97.37% and specificity of 100%. Muscle invasiveness was related to a higher BLCA-4 level (P=0.0175). Tumour tissues were also scored higher in staining (P=0.0001), yet this was not related to invasiveness. In 41.67% of adjacent normal tissue we found positive BLCA-4 expression. Urinary BLCA-4 was also highly specific in bladder cancer detection in the Chinese, with additional indicative value in muscle invasiveness detection. A cut-off value of 1.7×10⁻⁴ A may be more adaptive to Chinese Han population.

摘要

BLCA-4是目前膀胱癌最敏感且特异的尿液标志物。由于膀胱癌的发病率因种族和地域而异,我们倾向于评估在中国汉族人群中使用尿液BLCA-4检测膀胱癌的可行性。研究纳入了79例膀胱癌患者、31例尿路感染患者及29例正常对照者的尿液。还涉及53例膀胱癌、24例病理正常的肿瘤旁尿路上皮组织标本及15例健康对照的组织标本。制备了BLCA-4抗体,并将其应用于尿液样本的间接ELISA检测及组织样本的免疫组化研究。膀胱癌组尿液BLCA-4水平显著更高(P = 0.0001)。该水平与年龄、性别、生长模式、分级或分期无关。与已报道的数据不同,本研究获得的临界值为1.7×10⁻⁴ A,其灵敏度为97.37%,特异性为100%。肌层浸润性与较高的BLCA-4水平相关(P = 0.0175)。肿瘤组织的染色评分也更高(P = 0.0001),但这与浸润性无关。在41.67%的肿瘤旁正常组织中发现了BLCA-4阳性表达。尿液BLCA-4在中国人群膀胱癌检测中也具有高度特异性,在肌层浸润性检测方面具有额外的指示价值。临界值1.7×10⁻⁴ A可能更适用于中国汉族人群。

相似文献

1
Urinary BLCA-4 is highly specific for detection of bladder cancer in Chinese Han population and is related to tumour invasiveness.尿液BLCA-4在中国汉族人群中对膀胱癌检测具有高度特异性,且与肿瘤侵袭性相关。
Folia Biol (Praha). 2011;57(6):242-7.
2
BLCA-4 and UBC combined detection for early diagnosis of bladder cancer.BLCA-4与UBC联合检测用于膀胱癌的早期诊断。
J Biol Regul Homeost Agents. 2016 Apr-Jun;30(2):485-90.
3
Clinical usefulness of the novel marker BLCA-4 for the detection of bladder cancer.新型标志物BLCA-4在膀胱癌检测中的临床应用价值
J Urol. 2000 Sep;164(3 Pt 1):634-9. doi: 10.1097/00005392-200009010-00004.
4
Bladder Cancer-Specific Nuclear Matrix Proteins-4 May Be a Potential Biomarker for Non-Muscle-Invasive Bladder Cancer Detection.膀胱癌特异性核基质蛋白 4 可能成为非肌层浸润性膀胱癌检测的潜在生物标志物。
Dis Markers. 2018 Sep 10;2018:5609395. doi: 10.1155/2018/5609395. eCollection 2018.
5
Urine BLCA-4 exerts potential role in detecting patients with bladder cancers: a pooled analysis of individual studies.尿液BLCA-4在膀胱癌患者检测中发挥潜在作用:个体研究的汇总分析
Oncotarget. 2015 Nov 10;6(35):37500-10. doi: 10.18632/oncotarget.6061.
6
Highly specific urine-based marker of bladder cancer.膀胱癌高度特异性的尿液标志物。
Urology. 2005 Dec;66(6):1256-60. doi: 10.1016/j.urology.2005.07.010.
7
Use of the novel marker BLCA-1 for the detection of bladder cancer.新型标志物BLCA-1在膀胱癌检测中的应用。
J Urol. 2005 Jul;174(1):64-8. doi: 10.1097/01.ju.0000162022.36772.a4.
8
Urinary micro-RNA expressions and protein concentrations may differentiate bladder cancer patients from healthy controls.尿 microRNA 表达和蛋白浓度可能有助于区分膀胱癌患者与健康对照者。
Int Urol Nephrol. 2020 Mar;52(3):461-468. doi: 10.1007/s11255-019-02328-6. Epub 2019 Nov 2.
9
[Urinary BLCA-4 level is useful to detect upper urinary tract urothelial cell carcinoma].尿BLCA-4水平有助于检测上尿路尿路上皮癌。
Actas Urol Esp. 2012 Nov-Dec;36(10):597-602. doi: 10.1016/j.acuro.2012.03.018. Epub 2012 Sep 19.
10
Promoter methylation of DNA damage repair (DDR) genes in human tumor entities: / is almost exclusively methylated in bladder cancer.人类肿瘤实体中 DNA 损伤修复 (DDR) 基因的启动子甲基化:/ 在膀胱癌中几乎完全甲基化。
Clin Epigenetics. 2018 Feb 6;10:15. doi: 10.1186/s13148-018-0447-6. eCollection 2018.

引用本文的文献

1
New Trends and Future Perspectives in the Diagnosis of Urothelial Carcinoma: A Comprehensive Review of the Literature.尿路上皮癌诊断的新趋势与未来展望:文献综述
Medicina (Kaunas). 2025 Jan 3;61(1):71. doi: 10.3390/medicina61010071.
2
Current look at the most promising proteomic and glycomic biomarkers of bladder cancer.当前对膀胱癌最有前途的蛋白质组学和糖组学生物标志物的研究。
J Cancer Res Clin Oncol. 2024 Feb 19;150(2):96. doi: 10.1007/s00432-024-05623-7.
3
A Novel Multiepitope Vaccine Against Bladder Cancer Based on CTL and HTL Epitopes for Induction of Strong Immune Using Immunoinformatics Approaches.
一种基于CTL和HTL表位的新型膀胱癌多表位疫苗,利用免疫信息学方法诱导强烈免疫反应。
Int J Pept Res Ther. 2022;28(2):71. doi: 10.1007/s10989-022-10380-7. Epub 2022 Feb 24.
4
Comparing urine levels of BLCA-4 nuclear matrix protein in patients with bladder cancer and non-bladder cancer.比较膀胱癌患者和非膀胱癌患者尿液中BLCA-4核基质蛋白的水平。
Int J Physiol Pathophysiol Pharmacol. 2019 Dec 15;11(6):289-292. eCollection 2019.
5
Bladder Cancer-Specific Nuclear Matrix Proteins-4 May Be a Potential Biomarker for Non-Muscle-Invasive Bladder Cancer Detection.膀胱癌特异性核基质蛋白 4 可能成为非肌层浸润性膀胱癌检测的潜在生物标志物。
Dis Markers. 2018 Sep 10;2018:5609395. doi: 10.1155/2018/5609395. eCollection 2018.
6
The contemporary role and impact of urine-based biomarkers in bladder cancer.尿液生物标志物在膀胱癌中的当代作用及影响
Transl Androl Urol. 2017 Dec;6(6):1031-1042. doi: 10.21037/tau.2017.11.29.
7
The Diagnostic Value of Nuclear Matrix Proteins in Bladder Cancer in the Aspect of Environmental Risk from Carcinogens.核基质蛋白在膀胱癌中关于致癌物环境风险方面的诊断价值
Biomed Res Int. 2017;2017:9643139. doi: 10.1155/2017/9643139. Epub 2017 Aug 8.
8
A Systematic Review of the Diagnostic and Prognostic Value of Urinary Protein Biomarkers in Urothelial Bladder Cancer.尿蛋白生物标志物在上尿路上皮癌诊断和预后价值的系统评价
Bladder Cancer. 2016 Jul 27;2(3):301-317. doi: 10.3233/BLC-160054.
9
Urinary BLCA1 is specific for urothelial cancer detection in Chinese ethnicity.尿液中的BLCA1对中国人群的尿路上皮癌检测具有特异性。
Int J Clin Exp Med. 2015 Oct 15;8(10):18819-24. eCollection 2015.
10
BLCA1 expression is associated with angiogenesis of bladder cancer and is correlated with common pro-angiogenic factors.BLCA1表达与膀胱癌的血管生成相关,并与常见的促血管生成因子相关。
Int J Clin Exp Med. 2015 Sep 15;8(9):16259-65. eCollection 2015.